Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Infusion Clinic (Site 2806)

Osaka, 530-0011, JapanNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Ulcerative colitis

Running trials

Active, not recruiting
A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)
NCT06052059· Phase 3· Merck Sharp & Dohme LLC· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Infusion Clinic (Site 2806): trial site – Frontlight Research